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In the covalent binding of nitroarenes to macromolecules, nitroreduction is an important step. The intestinal microflora represents an enormous
potential of bacterial nitroreductase activity. As a consequence, the in vivo nitroreduction of orally administered nitroarenes is primarily located in the
intestine. In this study, we have investigated the nitroreduction of 2-nitrofluorene (2-NF) by a human microflora in female Wistar rats. Germ-free (GF)
rats were equipped with a bacterial flora derived from human feces. Nontreated GF rats and GF animals equipped with a conventional rat flora were
used as controls. The composition of the human and the conventional microflora isolated from the rats were consistent with the microflora of the
administered feces. In the rats receiving only sunflower seed oil, no adducts were detected. The animals equipped with a human or rat microflora
that received 2-aminofluorene (2-AF) formed 2-AF hemoglobin (Hb)-adducts at average levels (mean ± SEM) of 5.3 ± 0.3 and 6.7 ± 0.7 pmole/g Hb,
respectively. After 2-NF administration, the adduct levels were 0.022 ± 0.003 and 0.043 ± 0.010 pmole/g Hb, respectively. In the GF rats, an adduct
level of 0.57 ± 0.09 was determined after 2-AF administration and no adducts were detected after 2-NF administration. The results show that
nitroreduction by an acquired human intestinal microflora and subsequent adduct formation can be studied in the rat in vivo.
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Introduction
In the covalent binding of nitroarenes to
macromolecules, nitroreduction is the first
important step in N-directed metabolic
activation (1). The nitro group can either
be partially reduced to form a nitroso or an
N-hydroxyl intermediate or be completely
reduced to an amine (2,3). The amine can
be reoxidized to form N-hydroxyl products
and be further oxidized in the erythrocyte
to form a nitroso compound. This is a
reactive species that can bind covalently to
hemoglobin (Hb) (4,5).
Unlike other routes ofbiotransformation,
nitroreduction is not performed by the
intrinsic pool of enzymes present in body
tissues but primarily by enzymes ofbacteria
present in the intestine (6,7). In vivo only
a minor contribution is supplied by liver
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enzymes (8,9) or, presumably, by enzymes
in the lung (10,11). The intestinal microflora
represents an enormous potential ofbacterial
nitroreductase activity. Its metabolic capacity
depends on the presence of a community
of hundreds of aerobic and anaerobic bac-
terial species representing several billion
individual microorganisms. Each of the
bacterial strains can be considered an auto-
nomic metabolic unity. In this study, we
have investigated the formation of Hb-
adducts in germ-free (GF) rats that were
equipped with a human intestinal micro-
flora and in GF animals that were supplied
with a conventional rat microflora. We have
tried to establish the importance ofbacterial
nitroreduction as a first conditional step in
a cascade of metabolic activation reactions
eventually leading to macromolecular bind-
ing such as Hb adduct formation.
Methods
Animals
Home-bred GF female Wistar rats
(Cpb:WU) were equipped with either a
bacterial flora derived from human feces or
a rat flora. Rats without a microflora were
used as controls. The animals weighed 130
to 210 g, were housed individually in plastic
isolators, and had free access to autoclaved
sterilizable rat and mouse diet and water.
Microbiology
One and two weeks before the administra-
tion of the aryl compounds the microflora
was given by gavage. After collection ofthe
blood, the cecum was carefully tied up and
weighed. In the content of the cecum, the
total vital bacteria count was determined.
In addition, the following bacterial genera
were characterized by standard methods
(12) and counted: Enterobacteriaceae,
Staphylococci, Streptococci (aerobically cul-
tured), and Lactobacilli, Clostridia,
Bacteroides, Bifido bacteria, and Veillonella
(anaerobically cultured). The abundance of
yeasts and fungi was also determined.
AAmiitraion
In each ofthe groups of GF rats equipped
with a microflora, three rats received orally
1 mmole/kg 2-nitrofluorene (2-NF) dis-
solved in sunflower seed oil (SSO), three
rats received 1 mmole/kg 2-aminofluorene
(2-AF) in SSO and three rats were given
only SSO. Two GF rats received 2-AF in
SSO, two rats received 2-NF in SSO, and
two were given SSO only.
Chemicals
2-Aminofluorene (98%) was supplied by
Aldrich Europe (Bornem, Belgium). 7-
Fluoro-2-nitrofluorene (>99.8%) was
obtained from Sigma (St. Louis, MO).
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Table 1. Microbiologic characterization of rat and human feces and the microbiologic status (in logarithmic bacter-
ial counts) of GFWistar rats after 2 weeks of incubation with rat- and human-derived microfloras.
Rat microflora
Cecum Feces
Human microflora
Cecum Feces
Aerobic
Total aerobes 8.3 ± 0.2 9.5 8.9 ± 0.5 9.2
Streptococcussp. 6.5 ± 0.6 9.4 8.4 ± 0.4 6.5
Staphylococcussp. 4.1 ± 0.9 4.3 1.8 ± 0.1 6.3
Yeasts and fungi <2.7 0.1 <2.9 1.8± 0.1 3.5
Anaerobic
Total anaerobes 10.1 ± 0.2 9.8 10.5 ± 0.3 10.3
Enterobacteriaceae 7.2 ± 0.9 5.7 8.6 ± 0.5 9.0
Lactobacillussp. 7.7 ± 0.3 8.2 8.3 ± 0.7 8.4
Bacteroidessp. 9.2±0.4 8.8 10.1 ±0.3 9.4
Clostridiumsp. 8.6 ±0.5 9.2 9.3 ±0.3 9.0
Bifidobacteriumsp.a <2.8 ± 0.1 <2.9 8.1 ± 0.4 8.8
Veillonella sp. <3.0 ± 0.1 <2.9 4.6 ± 0.4 7.1
Totalcount 10.8±0.2 11.4 11.1±0.1 11.1
B. fragilisgroup.
Heptafluorobutyric anhydride (HFBA) and
2-nitrofluorene (98%) were supplied by
Janssen Chimica (Geel, Belgium), iso-
octane (HPLC-grade) from Fluka Chemica
(Brussels, Belgium), and SSO from OPG
(Utrecht, The Netherlands). Amberlite
XAD2 was supplied by Serva (Heidelberg,
Germany). 2-Amino-7-fluorofluorene was
obtained by the reduction ofthe aforemen-
tioned 7-fluoro-2-nitrofluorene with
hydrazine-monohydrate and Raney Nickel.
All other solvents used were HPLC-grade
(Lab-Scan Analytical Sciences, Dublin,
Ireland).
BloodAnalysis
Forty-eight hours after the administration
ofthe aryl compounds, blood was collected
by heart punction. After isolation of the
Hb, unbound 2-AF was removed by solid
phase extraction usingXAD2 (13). The Hb
concentration was determined according to
the hemiglobincyanide method (14). The
adducts were subsequently hydrolyzed
under mildly basic conditions (15).
2-Amino-7-fluorofluorene was added to
serve as an internal standard. The solution
was extracted overnight with XAD2. After
removing the Hb hydrolysate, the solid sor-
bent was washed and dried. The arylamines
were eluted with toluene and derivatized
with HFBA. 2-AF was determined using
GC-MS (coefficient ofvariance =14.1%).
Resufts
The characterization of the microbiologic
status of the rats is presented in Table 1.
The intestines of the previously GF rats
were efficiently colonized by both aerobic
and anaerobic species. The integrity ofthe
microflora is preserved considering the col-
onization of all genera of bacterial species
that were identified. There are only small
differences between the cecum populations
among the animals receiving a rat and a
human microflora.
The counts of Streptococcus are higher
in the administered rat feces than in the
ceca of the GF rats receiving this micro-
flora. The genera Enterobacteriaceae and
Bacteroides are more abundant relative to
the microflora ofthe conventional feces. In
the ceca ofrats receiving the human micro-
flora Staphylococcus, Veillonella, yeasts, and
fungi are less abundant as compared to the
administered feces. Aerobic as well as anaer-
obicculturing and gram preparations ofthe
cecum content indicated that the ceca of
the GF animals contained no microflora.
In Table 2 the relative cecum weights
are presented. The ceca ofthe GF rats had a
four times higher relative weight as com-
pared to the cecaweights ofthe animals that
received either a human or a rat microflora.
There is a minor difference between the ani-
mals that received a microflora derived
from human feces and the animals receiving
a rat feces-derived flora. This difference is
significant (p<0.05) in the two-tailed t-test.
Table 3 presents the Hb adduct levels
that were determined in the blood ofnon-
treated GF rats, GF animals equipped with
a human microflora, and GF animals with
a conventional rat microflora. The relative
adduct levels (± SEM) determined in the
bloodofrats thatreceived2-NF, as compared
to the adduct levels observed in animals
receiving 2-AF amounting to 0.3 ± 0.1%
and 0.8 ± 0.2% in animals equipped with a
human and a conventional rat microflora,
respectively.
Discussion
The composition of the human and the
conventional microflora isolated from the
rats was consistent with the microflora of
the source material (feces). The difference
in Hb-adduct formation of 2-NF between
animals equipped with a human-derived
microflora and animals equipped with a
flora originating from rat feces is a factor
also. This difference is not statistically sig-
nificant. Regarding the results obtained in
the GF rats, the nitroreducing capacity is
mainly located in the microflora.
Differences in the amounts of formed Hb
adducts could be related to the nitroreducing
capacity ofthe microflora. It is not known
what bacterial species or yeasts and fungi
are involved in this metabolic step. From in
vitro experiments it is known that some
anaerobic species such as Peptostreptococcus
and Peptococcus species, Bacteroides thetaio-
taomicron, Clostridium perfringens, and
Clostridium species are capable of nitrore-
duction of 1-nitropyrene (16) and 6-nitro-
benzo[a]pyrene (17). Aerobic species have
also been shown to reduce nitro aromatics
to some extent (18,19). The rat and human
intestinal microflora were found to be
capable of almost complete conversion of
6-nitro-benzo[a]pyrene (16) and 1-
nitropyrene (6). Human intestinal micro-
flora is known to reduce aromatic nitro
compounds in vitro (6,16).
Table 2. Relative cecum weights (± SEM) of GF rats
and ratsthatreceived a feces-derived rat microflora and
a human microflora, respectively.
No Rat Human
microflora microflora microflora
(n=6) (n=9) (n=9)
Relative cecum
weights, % 7.6± 0.4 2.1 ± 0.1 1.5± 0.1
Table 3. Levels of 2-AF Hb adducts (pmole/g Hb ± SEM) in rats that received either 1 mmole/kg 2-nitrofluorene or
1 mmole/kg 2-aminofluorene bygavage.
No Rat Human
Compound microflora microflora microflora
2-nitrofluorene NDa 0.043 ±0.010 0.022 ± 0.003
2-aminofluorene 0.57 ± 0.09 5.3 ± 0.3 6.7 ± 0.7
"Notdetected ata detection limit ofapproximately 0.1 pmole per injection or0.001 pmole 2-AF/g Hb.
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When the levels of Hb adducts deter-
mined in the blood ofanimals that received
a dose of2-AF were set on 100%, the levels
observed, in animals receiving 2-NF at the
same dose were found to be 0.8% in animals
equipped with a conventional rat micro-
flora. This represents the contribution ofthe
nitroreducing metabolic pathway to cova-
lent binding with Hb. Calculations on the
results, previously obtained by Suzuki and
coworkers (2) in Sprague-Dawley rats that
received 0.5 mmole/kg by gavage gave a
value of 0.9%. The extent of binding to
Hb is probably limited by N-hydroxylation
(2) or O-acetylation (20). The difference
in adduct formation cannot be explained
by any of the bacterial groups presented in
Table 1. Because it is known that a wide
range ofintestinal bacterial species are able
to reduce aromatic nitro compounds (16),
it is possible that species other than the
ones that were identified from the cecum
contents are responsible for the observed
difference in adduct formation. Qualitative
differences in the nitroreducing potential
between the microflora from humans, rhe-
sus monkeys, and rats are reported (21).
The difference between the Hb adduct lev-
els formed by the control animals equipped
with a human or rat microflora are not
statistically significant. In the GF rats, no
2-AF Hb adducts could be detected after
2-NF administration. The GF rats receiv-
ing 2-AF formed adducts at a much lower
level compared to the animals with a feces-
derived microflora. We suggest that this
difference is due to the GF status of the
rats and may be related to a change in the
resorption of2-AF from the intestine.
This study shows that nitroreduction
by an acquired human intestinal microflora
and subsequent adduct formation can be
studied in the rat in vivo. The intestinal
microflora contains a metabolic system
principally responsible for in vivo nitrore-
duction. This turns out to be a critical step
in the Hb adduct formation. We did not
observe a statistically significant difference
between the adduct formation in rats
equipped with a human microflora or a
conventional rat microflora. Because ofthe
maternal origin of the microflora in
humans, interindividual differences in the
composition can be expected. However, in
this study we did not consider possible dif-
ferences in nitroreducing capacity of the
microflora ofdifferent individuals. The dis-
tribution pattern of nitroreducing capaci-
ties of human microfloras is an interesting
topic in the human risk evaluation ofexpo-
sure to mixtures of nitro aromatics such as
diesel exhaust emissions.
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